Drug
Dutasteride clinical trials
Also written Avodart.
- studies test it
- 73
- open now
- 3
- in phase 3
- 16
- first study started
- 2003
Keep track of what changes. Save the Dutasteride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Avodart
- 23
Development codes
Studies by the year they started
73 studies that test it; most in 2006 (10)
| Year | Studies |
|---|---|
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 10 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 3 |
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 13
- Phase 2
- 26
- Phase 3
- 16
- Phase 4
- 15
- No phase
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 26 · Other 47
GlaxoSmithKline (23) · University of Washington (7) · UConn Health (5) · CHU de Quebec-Universite Laval (1) · University of Chicago (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1) · NorthShore University HealthSystem (1) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Tamsulosin (5) · Ketoconazole (4) · Testosterone (4) · Bicalutamide (2) · Finasteride (2) · Abiraterone Acetate (2) · Abiraterone (2) · Tadalafil (2)
Studies
Open first, then newest update. How each study uses Dutasteride is read from its arms, and is right about nine times in ten.
Testing it · 73
- Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder CancerRecruitingPhase 2Paul TorenNCT07420517Written as Dutasteride (0.5mg)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)Not yet recruitingNot applicableAssiut UniversityNCT07421804Written as topical dutasteride
- Phase II Dutasteride in Combination With CAB vs CAB in SDCRecruitingPhase 2Radboud University Medical CenterNCT05513365Written as Dutasteride 0.5 mg
- Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its ProgressionActive, not recruitingNot applicableCHU de Quebec-Universite LavalNCT01653925Written as Drug (Dutasteride) intervention first
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerActive, not recruitingNot applicableUniversity of ChicagoNCT01342367Written as Dutasteride
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of EfficacyCompletedPhase 2/3UConn HealthNCT04098302Written as Dutasteride Capsules
- Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.CompletedPhase 2Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalNCT05599243Written as Dutasteride
- Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate CancerCompletedPhase 2NorthShore University HealthSystemNCT00668642Written as Dutasteride
- Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)WithdrawnPhase 2Masonic Cancer Center, University of MinnesotaNCT05705700Written as Dutasteride
- Role of Dutasteride in Treatment of Chronic ProstatitisCompletedPhase 2/3Ain Shams UniversityNCT04756206Written as Dutasteride 0.5 mg
- EAT-DUTA AndroCoV TrialCompletedPhase 2/3Corpometria InstituteNCT04729491Written as Dutasteride 0.5 mg
- Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in TransmenCompletedPhase 3Unita Complessa di Ostetricia e GinecologiaNCT04545450Written as dutasteride 5 mg/day
- ITT-5 Mechanisms of Spermatogenesis in ManWithdrawnPhase 2University of WashingtonNCT02147964Written as Dutasteride
- Dutasteride to Treat Women With Menstrually Related Mood DisordersCompletedPhase 1National Institute of Mental Health (NIMH)NCT00082043Written as Dutasteride
- Dutasteride Treatment for the Reduction of Heavy Drinking in MenCompletedPhase 4UConn HealthNCT01758523Written as Dutasteride
- Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic HyperplasiaCompletedPhase 3GlaxoSmithKlineNCT02058368Written as Dutasteride 0.5mg capsules
- Sexual Function in Men Receiving Dutasteride for Androgenetic AlopeciaCompletedPhase 3Stiefel, a GSK CompanyNCT02014584Written as Dutasteride
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia SubjectsCompletedPhase 3GlaxoSmithKlineNCT00368979Written as Dutasteride
- Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate CancerTerminatedPhase 1/2Dana-Farber Cancer InstituteNCT00953576Written as dutasteride
- Prospective Sexual Function Study for BPH SubjectsCompletedPhase 4GlaxoSmithKlineNCT01777269Written as Dutasteride plus tamsulosin
See all 73 studies that test Dutasteride →
Given in every arm · 4 — Dutasteride is usual care beside what is tested
- Study of PCUR-101 in Combination With ADT in Patients With mCRPCTerminatedPhase 1Pellficure Pharmaceuticals, IncNCT04677855Written as Dutasteride 0.5 mg
- Safety and Pharmacokinetic Characteristics of DKF-313CompletedPhase 1Dongkook Pharmaceutical Co., Ltd.NCT02352311Written as AVODART
- Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate CancerCompletedPhase 2PfizerNCT01547299Written as Dutasteride
- Testosterone-Driven Growth-Hormone (GH) Secretion in Aging MenCompletedPhase 1Mayo ClinicNCT00309855Written as Dutasteride
As the comparator · 5 — what is tested is compared with Dutasteride
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic AlopeciaRecruitingPhase 3Chong Kun Dang PharmaceuticalNCT06916793Written as Dutasteride Capsules
- Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic HyperplasiaRecruitingPhase 1Universitas DiponegoroNCT07065682Written as Dutasteride (0.5mg)
- Efficacy and Safety of DKF-313 in Patients With Benign Prostatic HyperplasiaCompletedPhase 3Dongkook Pharmaceutical Co., Ltd.NCT04947631Written as Dutasteride
- Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate EnlargementCompletedPhase 4GlaxoSmithKlineNCT01294592Written as Dutasteride plus tamsulosin
- Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and TadalafilCompletedPhase 1Yuyu Pharma, Inc.NCT03240939Written as Dutasteride 0.5 mg
Codes
What other systems call Dutasteride · ClinicalTrials.gg INT006514
- MeSH (NLM) D000068538DutasterideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) O0J6XJN02IDUTASTERIDEConfirmed FDA, NLM, Wikidata
- RxNorm 228790Confirmed FDA, Wikidata
- Wikidata Q424760dutasterideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47503DutasterideOne source FDA
- DrugBank DB01126One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068538 | Dutasteride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | O0J6XJN02I | DUTASTERIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 228790 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424760 | dutasteride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47503 | Dutasteride | One source FDA |
| DrugBank | DB01126 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.